A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates
PHASE4CompletedINTERVENTIONAL
Enrollment
43
Participants
Timeline
Start Date
January 31, 2004
Primary Completion Date
April 30, 2005
Conditions
Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated